PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2014–2025

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	6	1
2021	—	5	1
2020	—	6	1
2019	—	8	1
2018	—	5	1
2017	—	5	1
2016	—	4	1
2015	—	4	1
2014	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
LEAVITT PARTNERS, LLC	—	59

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	21
Food & Drug Administration (FDA)	20
HOUSE OF REPRESENTATIVES	20
Health & Human Services, Dept of (HHS)	12
White House Office	12
Administration for Children & Families (ACF)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	22

PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) — Lobbying Disclosure | Poliscope